V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014814 | 220018189 | 1.79 | 71.8 | Palliative (P) | 2016-05-09 | 2016-05-09 | DAUNORUBICIN | 2 | N | 220035685 | CAPECITABINE |
| 220014815 | 220018189 | 1.53 | 29 | Palliative (P) | 2017-08-04 | 2017-08-04 | Capecitabine | N | null | 220035685 | CAPECITABINE + CARBOPLATIN |
| 220014816 | 220009434 | 1.75 | 87.4 | Curative (C) | 2017-02-08 | 2017-02-11 | Capecitabine | 02 | N | 220035734 | BEVACIZUMAB |
| 220014817 | 220009435 | 1.63 | 113 | null | 2015-01-05 | 2015-06-21 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | 220035735 | EOX |
| 220014818 | 220009436 | 1.63 | 112 | Palliative (P) | 2017-12-11 | 2017-12-15 | ROMAZA TRIAL | 2 | Y | 220035738 | CARBOPLATIN |
| 220014819 | 220009438 | 0 | 88 | Curative (C) | 2017-04-27 | 2017-06-10 | Ipilimumab | N | 2 | 220035738 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220014822 | 220015007 | 1.79 | null | Palliative (P) | 2014-09-09 | 2015-04-17 | IPILIMUMAB + NIVOLUMAB | N | N | 220035760 | BORTEZOMIB |
| 220014823 | 220009444 | null | null | Curative (C) | 2012-06-28 | 2013-08-31 | GEM-P | N | N | 220035762 | PAD |
| 220014824 | 220009445 | null | 60.4 | null | 2017-11-16 | 2017-11-23 | DOXORUBICIN | 2 | null | 220035765 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 220014825 | 220009446 | 1.7 | null | Curative (C) | 2017-01-26 | 2017-01-28 | CHLVPP | Y | null | 220035768 | MITOXANTRONE + TRETINOIN |
| 220014826 | 220009447 | 1.58 | 44.8 | Palliative (P) | 2014-11-30 | 2015-04-03 | ROMAZA TRIAL | 02 | N | 220035777 | CAPECITABINE + IRINOTECAN |
| 220014829 | 220009449 | null | null | Palliative (P) | 2013-08-20 | 2013-11-30 | BEP 5 Day | null | N | 220035783 | FIGARO TRIAL |
| 220014831 | 220021021 | 1.78 | 101.8 | Palliative (P) | 2015-09-05 | 2015-12-09 | Cisplatin + Pemetrexed | 2 | N | 220035790 | LI-1 TRIAL |
| 220014832 | 220009450 | 1.66 | 70.6 | null | 2016-09-08 | 2016-10-07 | ALL UKALL2011 Maintenance B3 | N | N | 220035793 | PEMBROLIZUMAB |
| 220014833 | 220015013 | 1.69 | 77.2 | Curative (C) | 2013-03-06 | 2014-05-04 | CLOFARABINE | null | N | 220035797 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE |
| 220014834 | 220018194 | 1.74 | null | Palliative (P) | 2018-07-28 | 2018-07-28 | FLUDARABINE | N | Y | 220035808 | BUSULFAN + CYCLOPHOSPHAMIDE |
| 220014835 | 220018194 | null | null | null | 2018-09-09 | 2018-09-14 | Etoposide oral | N | null | 220035808 | CAPECITABINE + OXALIPLATIN |
| 220014836 | 220021599 | 1.75 | 69 | null | 2013-12-08 | 2013-12-29 | TRASTUZUMAB | N | N | 220035815 | CLADRIBINE |
| 220014837 | 220009453 | 1.65 | 65.7 | Curative (C) | 2016-01-08 | 2016-01-09 | CHOP - 21 days | N | N | 220035840 | SPIRIT TRIAL |
| 220014838 | 220009455 | 1.75 | 82.9 | Palliative (P) | 2013-06-12 | 2013-10-17 | CYTARABINE + MITOXANTRONE | N | N | 220035846 | SPIRIT TRIAL |
| 220014840 | 220015016 | 1.64 | null | Curative (C) | 2014-03-18 | 2014-03-18 | BENDAMUSTINE + RITUXIMAB | null | N | 220035858 | CYCLOPHOSPHAMIDE + ETOPOSIDE HD |
| 220014841 | 220009458 | 1.67 | 87.5 | Palliative (P) | 2015-07-19 | 2015-12-17 | CAPECITABINE + GEMCITABINE | N | N | 220035866 | VENETOCLAX |
| 220014842 | 220009459 | null | null | Curative (C) | 2015-03-04 | 2015-03-09 | ALEMTUZUMAB + CYCLO + FLUDARABINE | N | N | 220035867 | MITOXANTRONE + TRETINOIN |
| 220014843 | 220015017 | 1.8 | null | Curative (C) | 2019-05-09 | 2019-05-15 | CYTARABINE + MITOXANTRONE | 01 | null | 220035870 | UKALLR3 |
| 220014844 | 220009460 | null | null | Curative (C) | 2015-08-05 | 2015-08-05 | EOX | N | null | 220035874 | EOX |
| 220014845 | 220009462 | null | null | Neo-adjuvant (N) | 2014-08-09 | 2014-08-09 | FLUDARABINE | N | null | 220035877 | DOXORUBICIN |
| 220014846 | 220009463 | 1.8 | 49.7 | Palliative (P) | 2016-07-23 | 2016-07-23 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | 220035878 | UKALL2011 |
| 220014847 | 220009463 | 1.78 | null | Curative (C) | 2015-04-20 | 2015-04-21 | ALL UKALL2011 Std Int Maint A | 02 | N | 220035878 | BENDAMUSTINE + RITUXIMAB |
| 220014848 | 220009465 | null | 79.6 | Disease modification (D) | null | 2016-03-17 | IVAC | 2 | N | 220035883 | IPILIMUMAB + NIVOLUMAB |
| 220014849 | 220009466 | 0 | 64.6 | Curative (C) | 2014-02-21 | 2014-02-27 | PEMBROLIZUMAB | N | N | 220035885 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 220014850 | 220009467 | 1.49 | 64 | Palliative (P) | 2012-06-18 | 2014-03-19 | Cisplatin + Radiotherapy | 02 | N | 220035891 | FCR |
| 220014851 | 220009467 | 0 | 73.8 | Disease modification (D) | 2013-04-15 | 2013-04-15 | Arsenic Triox + Tretinoin Ind W1-4 | null | N | 220035891 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 220014852 | 220009467 | 1.78 | 0 | Palliative (P) | 2016-12-09 | 2016-12-10 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 220035891 | ALEMTUZUMAB + CYCLO + FLUDARABINE |
| 220014854 | 220009469 | 1.7 | 52.5 | Palliative (P) | 2014-11-11 | 2015-01-06 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | 220035911 | CISPLATIN |
| 220014855 | 220009469 | null | 63.9 | Palliative (P) | 2016-09-25 | 2016-10-15 | MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | N | N | 220035911 | MACE |
| 220014856 | 220009470 | 1.71 | 102.4 | Palliative (P) | 2014-05-01 | 2014-05-01 | Arsenic Trioxide (Induction Week) | null | N | 220035925 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE |
| 220014857 | 220018196 | 1.55 | null | Curative (C) | 2015-03-17 | 2015-03-21 | FLUDARABINE | N | 2 | 220035925 | FLUDARABINE |
| 220014858 | 220009472 | null | 65.3 | Palliative (P) | 2013-08-14 | 2013-08-14 | FLUDARABINE | 02 | null | 220035943 | ARSENIC TRIOXIDE |
| 220014859 | 220009473 | 1.64 | 60.6 | Adjuvant (A) | null | 2016-05-25 | Cisplatin + Pemetrexed | 02 | N | 220035947 | VENETOCLAX |
| 220014860 | 220009477 | 1.6 | 65 | Palliative (P) | 2014-11-15 | 2014-11-15 | DABRAFENIB | 2 | N | 220035950 | TRASTUZUMAB |
| 220014861 | 220009478 | 1.65 | 81 | null | 2014-12-03 | 2014-12-03 | Bevacizumab 5mg/kg | 02 | N | 220035951 | DABRAFENIB |
| 220014862 | 220009478 | 1.68 | 83.9 | Palliative (P) | 2013-12-19 | 2014-03-28 | Alemtuzumab+Busulfan+CyclophosphMUD | null | null | 220035951 | MELPHALAN |
| 220014863 | 220018199 | 1.58 | 61 | Palliative (P) | null | 2017-02-04 | DOXORUBICIN | Y | null | 220035957 | CARBOPLATIN + LIPOSOMAL DOX |
| 220014864 | 220009479 | 1.69 | 72.5 | Adjuvant (A) | 2017-05-14 | 2017-05-26 | RAVVA TRIAL | N | N | 220035959 | BUSULPHAN |
| 220014865 | 220009481 | null | null | Palliative (P) | 2017-04-12 | 2017-04-12 | FLUDARABINE | 02 | N | 220035962 | DAUNORUBICIN |
| 220014866 | 220009482 | null | 67 | null | 2017-04-03 | 2017-04-03 | Bortezomib +/- Dexamethasone | N | null | 220035963 | METHOTREXATE HIGH DOSE |
| 220014867 | 220009483 | 1.75 | 100 | Curative (C) | null | 2016-06-01 | ALL UKALL2011 Maintenance A3 | N | N | 220035969 | CAPECITABINE |
| 220014868 | 220009484 | 1.74 | 108 | Not known (9) | 2014-11-04 | 2014-11-04 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 220035980 | SUNITINIB |
| 220014869 | 220015032 | 1.73 | 94.2 | Curative (C) | null | 2015-10-04 | Bevacizumab 5mg/kg | N | null | 220035982 | FIGARO TRIAL |
| 220014870 | 220015032 | 1.76 | 76.6 | Curative (C) | 2016-07-16 | 2016-08-05 | NIVOLUMAB | 02 | N | 220035982 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |